INQ000257098 – Press release from the Medicines and Healthcare products Regulatory Agency titled First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA, dated 04/11/2021.

  • نشرت: 8 سبتمبر 2025
  • تم تقديمه: 8 سبتمبر 2025
  • يكتب: شهادة
  • وحدة: الوحدة 4

Press release from the Medicines and Healthcare products Regulatory Agency titled First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA, dated 04/11/2021.

قم بتنزيل هذا المستند